1. Home
  2. ALDX vs TRVG Comparison

ALDX vs TRVG Comparison

Compare ALDX & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • TRVG
  • Stock Information
  • Founded
  • ALDX 2004
  • TRVG 2005
  • Country
  • ALDX United States
  • TRVG Germany
  • Employees
  • ALDX N/A
  • TRVG N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • ALDX Health Care
  • TRVG Technology
  • Exchange
  • ALDX Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • ALDX 304.9M
  • TRVG 306.5M
  • IPO Year
  • ALDX 2014
  • TRVG N/A
  • Fundamental
  • Price
  • ALDX $6.91
  • TRVG $4.12
  • Analyst Decision
  • ALDX Strong Buy
  • TRVG Buy
  • Analyst Count
  • ALDX 2
  • TRVG 4
  • Target Price
  • ALDX $10.00
  • TRVG $2.55
  • AVG Volume (30 Days)
  • ALDX 607.7K
  • TRVG 113.3K
  • Earning Date
  • ALDX 05-01-2025
  • TRVG 04-29-2025
  • Dividend Yield
  • ALDX N/A
  • TRVG N/A
  • EPS Growth
  • ALDX N/A
  • TRVG N/A
  • EPS
  • ALDX N/A
  • TRVG N/A
  • Revenue
  • ALDX N/A
  • TRVG $477,118,749.00
  • Revenue This Year
  • ALDX N/A
  • TRVG $9.85
  • Revenue Next Year
  • ALDX N/A
  • TRVG $6.77
  • P/E Ratio
  • ALDX N/A
  • TRVG N/A
  • Revenue Growth
  • ALDX N/A
  • TRVG N/A
  • 52 Week Low
  • ALDX $2.71
  • TRVG $1.60
  • 52 Week High
  • ALDX $7.20
  • TRVG $5.03
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 61.80
  • TRVG 56.05
  • Support Level
  • ALDX $6.79
  • TRVG $3.90
  • Resistance Level
  • ALDX $7.20
  • TRVG $4.29
  • Average True Range (ATR)
  • ALDX 0.56
  • TRVG 0.36
  • MACD
  • ALDX 0.03
  • TRVG -0.07
  • Stochastic Oscillator
  • ALDX 88.02
  • TRVG 38.57

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

Share on Social Networks: